Steinberg Global Asset Management’s Biogen BIIB Stock Holding History

Steinberg Global Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,538	Closed	-$417K	–	236
2017 Q2	$417K	Hold	1,538	–	–	0.06%	188
2017 Q1	$421K	Sell	1,538 -346	-18%	-$97.8K	0.07%	178
2016 Q4	$534K	Buy	1,884 +72	+4%	+$21.3K	0.09%	155
2016 Q3	$567K	Buy	1,812 +49	+3%	+$14.5K	0.1%	145
2016 Q2	$426K	Hold	1,763	–	–	0.07%	158
2016 Q1	$459K	Buy	1,763 +1,018	+137%	+$269K	0.09%	151
2015 Q4	$228K	Hold	745	–	–	0.04%	203
2015 Q3	$217K	Hold	745	–	–	0.04%	196
2015 Q2	$301K	Sell	745 -5	-0.7%	-$2.01K	0.06%	180
2015 Q1	$317K	Buy	750 +25	+3%	+$9.85K	0.06%	170
2014 Q4	$246K	Hold	725	–	–	0.05%	165
2014 Q3	$240K	Hold	725	–	–	0.05%	169
2014 Q2	$229K	Hold	725	–	–	0.05%	178
2014 Q1	$222K	Hold	725	–	–	0.06%	176
2013 Q4	$203K	Buy	+725	New	+$188K	0.04%	213

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steinberg Global Asset Management's BIIB Position: Q3 2017 in Review

Steinberg Global Asset Management sold out of Biogen (BIIB) in Q3 2017, closing a stake of 1,538 shares — an estimated $417K sold.

Steinberg Global Asset Management first reported a position in BIIB in Q4 2013 and held it in 15 quarters. The position peaked at $567K in Q3 2016. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

Steinberg Global Asset Management reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
Steinberg Global Asset Management sold 1,538 Biogen shares in Q3 2017, an estimated $417K.
Steinberg Global Asset Management first reported a position in Biogen in Q4 2013 and held it in 15 quarters.
Steinberg Global Asset Management's Biogen position peaked at $567K in Q3 2016.
1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Steinberg Global Asset Management's 13F filing for Q3 2017, filed 24 Oct 2017.